Literature DB >> 20228470

The epidemiology and clinical management of craniocerebral injury caused by the Sichuan earthquake.

Lu Jia1, Guo-Ping Li, Chao You, Hao Li, Si-Qing Huang, Chao-Hua Yang, Hai Xiong, Yi-Jun Zeng.   

Abstract

BACKGROUND: Earthquake is one of the most devastating natural disasters that threaten human lives. Worldwide more than 3 million deaths have been caused by earthquakes in recent 20 years. AIM: To analyze clinical features of head injuries after Sichuan earthquake.
MATERIALS AND METHODS: From May 12 to June 12, 2008, Departments of Neurosurgery in major Hospitals in Sichuan Province admitted 1368 patients with head injuries caused by the Sichuan earthquake; the epidemiology, mechanism, severity, complications, treatments and outcome of head injury were retrospectively analyzed.
RESULTS: Of the 1,368 patients, 755 were men and 613 women. Collapsing building was the most important cause of head injury. Most of the patients, 85% had mild to moderate head injury. The type of injury was open scalp injury in 65% of patients. About 47% of the head-injured patients were admitted within 72 h after earthquake. Skeletal bone fracture was the most common associated injury (9%). Only 98 patients received surgery. Glasgow Outcome Scale on discharge or transfer was: 5 in 1,121 (82%) patients, 4 in 173 (13%) patients, and 3 or less in 74 (5%) patients. Overall 33 (2%) patients died.
CONCLUSIONS: The characteristics of Sichuan earthquake-related head injury are quite distinct. Early standardized treatment is important to have better outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20228470     DOI: 10.4103/0028-3886.60406

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  1 in total

1.  Dynamic changes of α-melanocyte-stimulating hormone levels in the serum of patients with craniocerebral trauma.

Authors:  Xiaoguang Du; Baozhong Dong; Chen Li; Faxue Zhang; Yanwei Ji; Jianbin Zhang; Changjiang Yin
Journal:  Exp Ther Med       Date:  2017-07-12       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.